Total Payments
$13,943
2024 Payments
$381.60
Companies
8
Transactions
27
Medicare Patients
2,991
Medicare Billing
$497,191
Payment Breakdown by Category
Consulting$11,325 (81.2%)
Food & Beverage$1,932 (13.9%)
Travel$622.24 (4.5%)
Education$63.21 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,325 | 2 | 81.2% |
| Food and Beverage | $1,932 | 20 | 13.9% |
| Travel and Lodging | $622.24 | 3 | 4.5% |
| Education | $63.21 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $9,656 | 6 | $0 (2021) |
| Alnylam Pharmaceuticals Inc. | $2,869 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $422.36 | 4 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $406.27 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $280.44 | 5 | $0 (2022) |
| Novo Nordisk Inc | $146.99 | 2 | $0 (2021) |
| CALLIDITAS THERAPEUTICS US INC. | $115.37 | 1 | $0 (2024) |
| Integra LifeSciences Corporation | $45.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $381.60 | 4 | Alexion Pharmaceuticals, Inc. ($220.77) |
| 2023 | $260.35 | 4 | Alexion Pharmaceuticals, Inc. ($185.50) |
| 2022 | $13.09 | 1 | Otsuka America Pharmaceutical, Inc. ($13.09) |
| 2021 | $12,611 | 11 | Veloxis Pharmaceuticals, Inc. ($9,656) |
| 2019 | $124.63 | 1 | Otsuka America Pharmaceutical, Inc. ($124.63) |
| 2018 | $449.70 | 5 | Novartis Pharmaceuticals Corporation ($320.03) |
| 2017 | $102.33 | 1 | Novartis Pharmaceuticals Corporation ($102.33) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $102.21 | General |
| Category: Rare Disease | ||||||
| 05/23/2024 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $45.46 | General |
| Category: Recon-Skin and Wound | ||||||
| 05/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $115.37 | General |
| Category: Nephrology | ||||||
| 03/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $118.56 | General |
| Category: Rare Disease | ||||||
| 06/06/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Genetic Disease | ||||||
| 06/05/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $88.63 | General |
| Category: Rare Disease | ||||||
| 03/14/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $96.87 | General |
| Category: Rare Disease | ||||||
| 01/13/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Education | In-kind items and services | $46.65 | General |
| Category: Genetic Disease | ||||||
| 01/12/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEPHROLOGY | ||||||
| 12/07/2021 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Genetic Disease | ||||||
| 10/29/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $8,625.00 | General |
| Category: Immunosuppresant | ||||||
| 10/29/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $286.23 | General |
| Category: Immunosuppresant | ||||||
| 10/29/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $270.00 | General |
| Category: Immunosuppresant | ||||||
| 10/29/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $239.03 | General |
| Category: Immunosuppresant | ||||||
| 10/29/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | In-kind items and services | $96.98 | General |
| Category: Immunosuppresant | ||||||
| 10/27/2021 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEPHROLOGY | ||||||
| 07/28/2021 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $94.40 | General |
| Category: Genetic Disease | ||||||
| 05/20/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $110.36 | General |
| Category: Diabetes | ||||||
| 05/20/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $36.63 | General |
| 04/14/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $139.12 | General |
| Category: Immunosuppresant | ||||||
| 05/07/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $124.63 | General |
| Category: NEPHROLOGY | ||||||
| 12/11/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $115.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $16.56 | General |
| Category: NEPHROLOGY | ||||||
| 09/19/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $93.33 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2018 | Novartis Pharmaceuticals Corporation | MYFORTIC (Drug), ZORTRESS | Food and Beverage | In-kind items and services | $111.20 | General |
| Category: TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 596 | 1,255 | $572,651 | $110,383 |
| 2022 | 11 | 693 | 1,382 | $485,506 | $110,623 |
| 2021 | 12 | 791 | 1,639 | $590,068 | $138,657 |
| 2020 | 12 | 911 | 1,838 | $651,480 | $137,528 |
Total Patients
2,991
Total Services
6,114
Medicare Billing
$497,191
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 264 | 522 | $223,938 | $49,230 | 22.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 104 | 396 | $172,656 | $34,509 | 20.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 113 | $34,239 | $6,506 | 19.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 54 | $45,522 | $6,298 | 13.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 49 | $21,021 | $4,761 | 22.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 37 | 38 | $16,986 | $3,062 | 18.0% |
| 50200 | Needle biopsy of kidney | Facility | 2023 | 15 | 17 | $32,555 | $1,580 | 4.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $6,798 | $1,507 | 22.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $9,168 | $1,482 | 16.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 12 | 17 | $6,732 | $927.01 | 13.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 15 | 22 | $3,036 | $521.62 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 287 | 547 | $234,663 | $52,795 | 22.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 113 | 365 | $100,740 | $26,861 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 210 | $35,490 | $10,053 | 28.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 67 | $31,624 | $8,968 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 29 | $12,441 | $3,044 | 24.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 34 | 35 | $8,855 | $2,523 | 28.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 23 | 41 | $16,236 | $1,947 | 12.0% |
| 50200 | Needle biopsy of kidney | Facility | 2022 | 18 | 18 | $34,470 | $1,237 | 3.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 17 | 17 | $3,995 | $1,209 | 30.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 30 | $2,820 | $878.22 | 31.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $1,892 | $575.12 | 30.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $2,280 | $533.22 | 23.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 332 | 762 | $326,898 | $76,603 | 23.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 112 | 309 | $85,284 | $22,596 | 26.5% |
About Dr. Anthony Langone, MD
Dr. Anthony Langone, MD is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841387974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Langone, MD has received a total of $13,943 in payments from pharmaceutical and medical device companies, with $381.60 received in 2024. These payments were reported across 27 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($11,325).
As a Medicare-enrolled provider, Langone has provided services to 2,991 Medicare beneficiaries, totaling 6,114 services with total Medicare billing of $497,191. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Nashville, TN
- Active Since 10/09/2006
- Last Updated 03/25/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1841387974
Products in Payments
- Envarsus (Drug) $9,656
- OXLUMO (Drug) $2,841
- ZORTRESS (Drug) $311.16
- ULTOMIRIS (Biological) $309.40
- JYNARQUE (Drug) $167.33
- TARPEYO (Drug) $115.37
- SAMSCA (Drug) $113.11
- MYFORTIC (Drug) $111.20
- Ozempic (Drug) $110.36
- SOLIRIS (Biological) $96.87
- Integra (Device) $45.46
- GIVLAARI (Drug) $28.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Nephrology $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Nephrology $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Nephrology $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Nephrology $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Nephrology $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757
Nephrology $33,757